Search

Corporations and stock exchanges are considered the "heart of capitalism" because they are responsible for the creation of inventions, new technologies, and entire industries in the past two centuries, and thus, through their actions, have significantly supported technological and social progress. Since the second half of the 19th century, German corporations have played the role of a pillar of the German economy and Germany has become one of the most economically developed European countries. Despite its economic importance, the German corporate language, as a segment of Business German (German: Wirtschaftsdeutsch), has not been significantly researched. This corpus linguistics paper presents the results of diachronic research of multi-word expressions in the annual reports of corporations from the three most important DAX Prime Standard indices, created by the German Stock Exchange (German: Deutsche Börse) from Frankfurt am Main – DAX, MDAX, and S-DAX. The subject of the linguistic analysis is the annual reports of 11 German corporations for the fiscal years 1997 and 2022. The results of the analysis show changes in the lexicon in the German corporate language over the past 25 years and can be a stimulus for further corpus research in that area. The results of the research can also have pedagogical implications because they can be used to create various types of lexical exercises in Business German classes, which contain the latest vocabulary from that field.

Copyright of Social Sciences & Humanities Studies / Društvene i Humanističke Studije (DHS) is the property of Faculty of Humanities & Social Sciences, University of Tuzla and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Recently, the energy sector has faced numerous challenges due to the effects of climate change. Primarily, this includes reduced electricity production in hydroelectric plants due to changes in seasonal rainfall distribution, as well as increased electricity consumption for cooling needs, driven by the ongoing trend of rising air temperatures. Additionally, damage to energy facilities and infrastructure from extreme weather events such as ice jams, floods, and others are plausible scenarios worldwide, among many other issues stemming from climate change consequences.One of the primary drivers of climate disruption, specifically global temperature rise, is the increasing presence of greenhouse gases in the atmosphere, primarily from fossil fuel combustion. To mitigate the emission of these harmful gases, limit global warming, and improve ambient air quality, one emerging solution is the expanded use and application of renewable energy sources. This energy approach brings significant environmental preservation benefits, thereby reducing the emission of harmful gases that significantly contribute to global warming. Therefore, this paper will predominantly discuss various benefits of utilizing renewable energy sources, considered pivotal in decarbonization efforts aimed at mitigating climate change. [ABSTRACT FROM AUTHOR]

With regard to systemic oncological treatments, correlation of the use of immunotherapy with checkpoint inhibitors with the risk of more severe COVID-19 infection is uncertain. However, benefits of immunotherapy in the disease caused by the new coronavirus completely suppressed the initial fear of expected negative impacts of immune system triggered by checkpoint inhibitors. By preventing CD8 + lymphocyte exhaustion, reducing interleukin-6 levels, and indirectly regulating neutrophils and NK cells, immunotherapy affects the pathophysiology of COVID-19. The current findings highlight immunotherapy as a safe option of cancer treatment at the time of COVID-19 pandemic. [ABSTRACT FROM AUTHOR]

Copyright of Medicina Fluminensis is the property of Croatian Medical Association, Rijeka Branch & Faculty of Medicine, University of Rijeka and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Timocki Medicinski Glasnik is the property of Timocki Medicinski Glasnik and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Lijecnicki Vjesnik is the property of Croatian Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Lijecnicki Vjesnik is the property of Croatian Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Medicus (1330-013X) is the property of Pliva Hrvatska d.o.o. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Lijecnicki Vjesnik is the property of Croatian Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Medical Journal / Medicinski Časopis is the property of Serbian Medical Society, Section Kragujevac and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Polemos is the property of Croatian Sociological Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Epidemiolog Zavoda je stručni koordinator za imunizacije za teritoriju Borskog okruga i Zaječarskog okruga. Na teritoriji oba okruga živi 228.938 stanovnika. (Popis 2011., R. Srbija 7,120.666) Za primovakcinaciju u 2018.g. planirana su 1.423 deteta što je ukupno gledano za oba okruga za petinu manje nego pre deset godina. U radu smo prikazali procente obuhvata vakcinama poslednjih deset godina sprovođenja Programa obavezne intimizacije lica određenog uzrasta. I decenijanta unazad, od kada Zavod vrši ovu vrstu nadzora, registrovali smo zadovoljavajuće procente obuhvata svim obaveznim vakcinama. Zahvaljujući aktivnoj koordinaciji Zavoda na teritoriji oba okruga, čak i u periodu neredovnog snabdevanja pojedinim vakcinama, uspeli smo da obezbedimo, zajedno sa Institutom za javno zdravlje Srbije, da službe imaju potrebne količine vakcina i vakcinuišu svu planiranu decu. Problemi sa nižim procentima obuhvata od planiranih 95% počeli su od 2015.g. Prvi poremećaj je izazvalo tromesečno kašnjenje novouvedene petovalentne vakcine. Neke službe su pod pritiskom roditelja koji nisu hteli da produžavaju vrenie započinjenja primovakcinacije, posebno DTP vakcinom te godine davali tu vakcinu koja im je bila na raspolaganju iz prethodnog perioda. Zato su se procenti obuhvata, te godine, razlikovali od službe do službe. Glavni problemi sa smanjenim obuhvatom koji je ozbiljno zahvatio skoro sve naše vakcinalne službe počeo je 2015. na 2016.g., a u Boru još od 2014.g. To se prvenstveno odnosi na primovakcinaciju MMR vakcinom, a u nekim gradovima i na vakcinaciju protiv VHB. U oba slučaja možemo reći da taj odnos roditelja prema do tada skoro besprekornom odzivu na vakcinaciju koincidirao sa pojačanim dejstvima antivaksera, prventveno njihovim aktivnim negativnim delovanjem na društvenim mrežama. I Zavod, ali i službe za vakcinaciju, zajedno sa drugim epidemiolozima na oba okmga činili smo dodatne napore da opovrgnemo neistine i obmane kojima su roditelji bili zavedeni, ali sve do pojave epidemije morbila nismo imali značajnijih rezultata u povećanju procenata obuhvata ovom vakcinom. Sa početkom epidemije intezivirali smo, zajedno sa skužbama za vakcinaciju, rad na ponovnmom pozivanju nevakcinisane dece kod kojih su roditelji odbijali da ih do tada dovedu na vakcinaciju. Svesrdnim zalaganjem pre svih neposrednih realizatora vakcinacije, za manje od četiri meseca, postignuti su skoro zadovoljavajući procenti obuhvata čak i u Buru i Zaječaru koji su prednjačili po broju nevakcinisane dece, posebno kod primovakcinacije u drugoj godini. Ono što, i pored velikog smanjenja nevakcinisane dece, zabrinjava jeste podatak da je i dalje najveći broj nevakcinisane dece u drugoj godini života. Taj broj nevakcinisanih se prenosi i u treću godinu života. Dakle, i dalje postoji tzv. „odlaganje” vakcinacije dok dete „ne prohoda i ne progovori” ! Što je bio najčešći „izgovor” roditelja zašto i dalje ne dovode decu na vakcinaciju. Na kraju prikazujemo osnovne epidemiološke podatke iz epidemije malih boginja koja se pojavila i na teritoriji oba okruga. Prvi slučaj prijavljen u ovoj epidemiji bilo je dete iz Knjaževca, starosti 15 meseci. Dete je u vreme zaražavanja prvobitno hospitalizovano u Beogradu - kojem je već bila prijavljena epidemija malih boginja - na Univerzitetskoj dečijoj klinici, a zatim je prebačeno na Dečju internu kliniku u Nišu, gde je takođe već bila prijavljena epidemija. Pprijava uz pozitivan laboratorijski nalaz IgM At poslao je IJZ Niš. Od tada do 23/04/2018. prijavljeno je 56 slučajeva sumnje od kojih je 33 laboratorijski potvrđeno. Prvi slučajevi sumnje koji su prijavljeni u Boru i Zaječaru bila su deca koja su bila ili hospitalizovana ili na pregledu u ustanovama tercijarne zdravstvene zaštitie zbog drugih tegoba u Beogradu i Nišu. Među obolelim su i roditelji dece koji su vodili decu na pregled u ove zdravstvene ustanove. Nakon tih početnih slučajeva novi oboljenja su bili „domaći” slučajevi koji su u vreme zaražavanja ili negovali obolelu hospitalizovanu decu, ili roditelji druge dece koju su u isto vreme dovodila na pregled na Dečje odeljenje u Boru i Zaječaru. Epidemiološki jako bitna karakteristika ove epidemije jeste pojava većeg broja lica koja su bila sa laboratorijski potvrđenim IgM antitelima, a vakcinisan su sa jednom dozom vakcine, njih 16, ili sa čak dve doze vakcine, njih osmoro, a ipak su imali kliničku sliku koju je potvrdio svojim pregledom infektolog. Zato će kolega infektolog nastaviti ovu temu svojom analizom ove epidemije. [ABSTRACT FROM AUTHOR]